Stock Taper
SCREENER COMPARE ANY 2 STOCKS
DXR
DAXOR CORPORATION
NASDAQ
$10.20
▲ UP 5.48% (0.53)

KEY STATISTICS

Market Cap$59.55 M
52w High$14.76
52w Low$8.56
Dividend Yield1.43%
FrequencyMonthly
P/E5.62
Volume13.16K
Shares Out.5.84M

COMPANY

LEADERSHIP

Michael Richard Feldschuh
CHIEF EXECUTIVE
Michael Richard Feldschuh

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 25, 1983
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
37

PRICE TARGET

Target High$23.00
Target Low$23.00
Target Median$23.00
Target Consensus$23.00

UPCOMING EARNINGS

DateAug 31, 2026
DayMonday
Rev. Est.$2.80M
AUG
31
MON

PRICE

$10.20 ▲ UP 5.48% (+$0.53)
$9.75$10.00$10.25$10.509:30 AM10:35 AM11:39 AM12:44 PM1:48 PM2:52 PM3:57 PM10.20

About Daxor Corporation

https://www.daxor.com ↗

Daxor Corporation, founded in 1971 and based in Oak Ridge, Tennessee, develops and markets the BVA-100 Blood Volume Analyzer to provide accurate blood volume testing for various medical and surgical conditions.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT DAXOR CORPORATION IS KNOWN FOR

BVA-100 Blood Volume Analyzer
BVA-100 Blood Volume Analyzer

The BVA-100 is an FDA-cleared device that accurately measures blood volume, enabling healthcare professionals to make personalized fluid management decisions for conditions like heart failure, critical care, and kidney failure.

COMPETITORS

COMPETITOR
ABT COMPARE
BAX COMPARE
EW COMPARE
ICUI COMPARE
MA MASI COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
10
LISTED HERE
1
RANKED BY POSITION SIZE
VTS.AX
0.00% · 48.8K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
7.49%
HOLDERS
20
TOP 12 OF 20 · RANKED BY POSITION SIZE
Thompson Siegel & Walmsley LLC
232.1K sh · $2.25M
Vanguard Group Inc
49.0K sh · $723.16K
Aristides Capital LLC
41.7K sh · $403.16K
Renaissance Technologies LLC
28.9K sh · $398.1K
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
25.2K sh · $244.87K
Keyes, Stange & Wooten Wealth Management, LLC
15.9K sh · $155.8K
Susquehanna International Group, Llp
13.7K sh · $133.36K
NC
Nano Cap New Millennium Growth Fund L P
12.5K sh · $184.38M
Crescent Grove Advisors, LLC
10.7K sh · $103.69K
Morgan Stanley
3.5K sh · $48.69K
Sbi Securities Co., Ltd.
3.1K sh · $46.14K
Ubs AG
905 sh · $6K

RATINGS SNAPSHOT

Overall rating: A-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets5
Debt To Equity4
Price To Earnings3
Price To Book3
Overall Score4

INSIDER TRADES

★
DIRECTOR
Cremisi Henry D.
Purchase · 2.5K shares
2026-06-23
★
DIRECTOR, OFFICER: CHIEF SCIENTIFIC OFFICER
Feldschuh Jonathan Adam
Purchase · 25.0K shares
2026-06-23
★
DIRECTOR
DesRosiers Caleb
Purchase · 2.5K shares
2026-06-23
★
OFFICER: CHIEF FINANCIAL OFFICER
Michel Robert J
Purchase · 12.0K shares
2026-06-23

SECTORS PEERS

PEERPRICE
ADAG$3.68COMPARE
ACET$9.06COMPARE
GANX$1.77COMPARE
XBIT$2.27COMPARE
GEG$2.16COMPARE
NRXP$3.55COMPARE
NEPH$4.55COMPARE
LITS$0.98COMPARE